ArticleLife science alliance2019

Inhibition of host NOX1 blocks tumor growth and enhances checkpoint inhibitor-based immunotherapy.

Jimmy Stalin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.